Janice Chen

Janice Chen is the co-founder and CTO of Mammoth Biosciences, a biotechnology company harnessing a revolutionary gene-editing tool called CRISPR to deliver on the promise of precision medicine across diagnostics and therapeutics. Based in the San Francisco Bay Area, Mammoth Biosciences is harnessing the diversity of nature to power the next generation of CRISPR products. Through its discovery of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. Janice received her PhD from the lab of Nobel Laureate Professor Jennifer Doudna at University of California, Berkeley. She investigated mechanisms of CRISPR proteins and developed technologies leading to multiple papers and patents, and co-invented the programmable CRISPR-based detection technology called DETECTR. Janice was selected as a Forbes 30 Under 30 in Healthcare, Business Insider's 30 Under 40 in Healthcare, Endpoints Top 20 Women in Biopharma and delivered a TEDx talk on the potential for CRISPR to democratize diagnostics.